GARY JOHNSON: Open Payments
NPI 1114013513 · SAN ANDREAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 67 payments from 14 companies in 2025. Trend: 2023 $470 · 2024 $634 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 50 | $777 |
| Amgen Inc. | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
Products named: Korlym, EVENITY, REXULTI, Kerendia, MOUNJARO, ZENPEP, LEQVIO, CAPLYTA.
Industry payments across CA — which companies pay providers there.
